Corrigendum to: LCZ696, Angiotensin II Receptor-Neprilysin Inhibitor, Ameliorates High-Salt-Induced Hypertension and Cardiovascular Injury More Than Valsartan Alone. (2nd December 2021)

Record Type:
Journal Article
Title:
Corrigendum to: LCZ696, Angiotensin II Receptor-Neprilysin Inhibitor, Ameliorates High-Salt-Induced Hypertension and Cardiovascular Injury More Than Valsartan Alone. (2nd December 2021)
Main Title:
Corrigendum to: LCZ696, Angiotensin II Receptor-Neprilysin Inhibitor, Ameliorates High-Salt-Induced Hypertension and Cardiovascular Injury More Than Valsartan Alone
Authors:
Kusaka, Hiroaki
Sueta, Daisuke
Koibuchi, Nobutaka
Hasegawa, Yu
Nakagawa, Takashi
Lin, BoWen
Ogawa, Hisao
Kim-Mitsuyama, Shokei
Abstract:
Is Part Of:
American journal of hypertension. Volume 35:Number 2(2022)
Journal:
American journal of hypertension
Issue:
Volume 35:Number 2(2022)
Issue Display:
Volume 35, Issue 2 (2022)
Year:
2022
Volume:
35
Issue:
2
Issue Sort Value:
2022-0035-0002-0000
Page Start:
208
Page End:
208
Publication Date:
2021-12-02
Subjects:
Hypertension -- Periodicals
616.132005
Journal URLs:
http://ajh.oxfordjournals.org/ ↗
http://www.nature.com/ajh/index.html ↗
http://ukcatalogue.oup.com/ ↗
http://www.sciencedirect.com/science/journal/08957061 ↗
DOI:
10.1093/ajh/hpab149 ↗
Languages:
English
ISSNs:
0895-7061
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 0826.400000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
20687.xml